International Scholarly Research Notices / 2013 / Article / Fig 1

Research Article

Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy

Figure 1

(a) Percent CD4+, (b) percent CD8+, and (c) CD4+/CD8+ ratio in virologically suppressed patients. Line represents median; rank-sum test; BL: baseline.

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.